We are live on ! Find out more
Dimensional Fund Advisors

Dimensional Fund Advisors Portfolio holdings

AUM $481B
1-Year Est. Return 30.42%
 

Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.

This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+30.42%
3 Year Est. Return
+88.16%
5 Year Est. Return
+120.13%
10 Year Est. Return
+468.8%
AUM
$314B
AUM Growth
+$16.9B
Cap. Flow
+$2.33B
Cap. Flow %
0.74%
Top 10 Hldgs %
12.02%
Holding
3,572
New
111
Increased
1,840
Reduced
1,366
Closed
91

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$272M
2
CVX icon
Chevron
CVX
+$206M
3
TSLA icon
Tesla
TSLA
+$153M
4
NVDA icon
NVIDIA
NVDA
+$143M
5
PFE icon
Pfizer
PFE
+$131M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$242M
2
FSLR icon
First Solar
FSLR
+$153M
3
WMT icon
Walmart Inc
WMT
+$133M
4
STLD icon
Steel Dynamics
STLD
+$115M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$109M

Sector Composition

Rank Sector Weight
1 Technology 17.92%
2 Financials 15.55%
3 Industrials 13.68%
4 Consumer Discretionary 11.04%
5 Healthcare 10.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NHTC icon
3176
Natural Health Trends
NHTC
$14.4M
$278K ﹤0.01%
50,733
+5,851
+13% +$32K
ABCM
3177
DELISTED
Abcam PLC
ABCM
$277K ﹤0.01%
11,301
-26
-0.2% -$449
PWP icon
3178
Perella Weinberg Partners
PWP
$1.09B
$276K ﹤0.01%
+33,191
New +$274K
ZVRA icon
3179
Zevra Therapeutics
ZVRA
$570M
$275K ﹤0.01%
53,882
GAMB
3180
DELISTED
Gambling.com
GAMB
$274K ﹤0.01%
+26,769
New +$268K
PDSB icon
3181
PDS Biotechnology
PDSB
$39.1M
$274K ﹤0.01%
54,433
-287
-0.5% -$1.88K
LENZ
3182
LENZ Therapeutics
LENZ
$181M
$273K ﹤0.01%
15,025
+7,631
+103% +$152K
CARM
3183
DELISTED
Carisma Therapeutics
CARM
$273K ﹤0.01%
31,152
-1,296
-4% -$7.06K
SWKH
3184
DELISTED
SWK Holdings
SWKH
$272K ﹤0.01%
20,473
ADV icon
3185
Advantage Solutions
ADV
$540M
$271K ﹤0.01%
4,630
+641
+16% +$27.4K
TRML
3186
DELISTED
Tourmaline Bio
TRML
$269K ﹤0.01%
+8,847
New +$226K
SELF
3187
Global Self Storage
SELF
$58.1M
$264K ﹤0.01%
52,323
+2,500
+5% +$12.7K
MNOV icon
3188
MediciNova
MNOV
$66M
$264K ﹤0.01%
114,773
+4,737
+4% +$10.4K
LTBR icon
3189
Lightbridge
LTBR
$277M
$263K ﹤0.01%
45,263
-1,125
-2% -$4.97K
COFS icon
3190
Choiceone Financial
COFS
$506M
$262K ﹤0.01%
+11,390
New +$264K
GEVO icon
3191
Gevo
GEVO
$372M
$261K ﹤0.01%
171,407
-130,746
-43% -$169K
THRN
3192
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$258K ﹤0.01%
54,941
CCLD icon
3193
CareCloud
CCLD
$102M
$258K ﹤0.01%
87,487
-39,714
-31% -$126K
NCSM icon
3194
NCS Multistage Holdings
NCSM
$119M
$256K ﹤0.01%
14,482
-1,428
-9% -$27.6K
PMD
3195
DELISTED
Psychemedics Corporation
PMD
$256K ﹤0.01%
56,155
-407
-0.7% -$2.06K
GLUE icon
3196
Monte Rosa Therapeutics
GLUE
$1.92B
$255K ﹤0.01%
37,268
FUSB icon
3197
First US Bancshares
FUSB
$93M
$252K ﹤0.01%
29,597
-700
-2% -$5.27K
BTAI icon
3198
BioXcel Therapeutics
BTAI
$24.5M
$251K ﹤0.01%
2,354
-1,486
-39% -$495K
ITCL
3199
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
$249K ﹤0.01%
71,294
CRBP icon
3200
Corbus Pharmaceuticals
CRBP
$168M
$248K ﹤0.01%
31,600
+17,919
+131% +$161K

Similar funds

Dimensional Fund Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Dimensional Fund Advisors held 3,572 positions worth $314B, up 5.7% from $297B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Dimensional Fund Advisors's Q2 2023 filing shows 111 new, 1,840 increased, 1,366 reduced and 91 closed positions. Its largest new stake was Knife River: 1,268,239 shares worth $55.2M. The largest sale was Apple, an estimated $242M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.

  • Dimensional Fund Advisors's largest Q2 2023 buy was Knife River: 1,268,239 shares worth $55.2M.
  • Dimensional Fund Advisors added most to ExxonMobil in Q2 2023, an estimated $272M increase.
  • Dimensional Fund Advisors's biggest Q2 2023 reduction was Apple, cutting an estimated $242M.
  • Dimensional Fund Advisors fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $102M.
  • Dimensional Fund Advisors's ten largest holdings make up 12% of its $314B portfolio in Q2 2023.
  • Dimensional Fund Advisors opened 111 new positions and closed 91 in Q2 2023.
  • Dimensional Fund Advisors's portfolio value rose 5.7% quarter-over-quarter to $314B.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.